North America Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country
Market Introduction
Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.
Get more information on this report :
Market Overview and Dynamics
The North America nasal delivery devices market is expected to reach US$ 36,940.74 million in 2027 from US$ 21,932.47 million in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020-2027. The growth of the market is attributed to some key driving factors such as the rising prevalence of respiratory diseases and the superior outcomes of intranasal drug delivery among patients. However, the market growth is likely to be hindered owing to the limitations regarding drug delivery medications.
Key Market Segments
Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.
Major Sources and Companies Listed
Some of the major primary and secondary sources for nasal delivery devices market included in the report are Global Asthma Network, US National Library of Medicine National Institutes of Health, and others.
Reasons to buy the report
- To understand the North America nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
- Efficiently plan M&A and partnership deals in North America nasal delivery devices market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region
NORTH AMERICA NASAL DELIVERY DEVICES MARKET SEGMENTATION
- Anaesthetics
- Antibiotics
- Pain Relief Drugs
- Calcium Supplements
- Vasoconstrictors
- Antihistamines
- Others
- Spray
- Nebulizers
- Inhalers
- Others
- Home Care Settings
- Hospitals
- Clinics
By Country
- North America
- US
- Canada
- Mexico
Company Profiles
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc.
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Nasal Delivery Devices Market – By Drug Type
1.3.2 Nasal Delivery Devices Market – By Delivery Technologies
1.3.3 Nasal Delivery Devices Market – By End User
1.3.4 North America Nasal Delivery Devices Market – By Country
2. North America Nasal Delivery Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Nasal Delivery Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Nasal Delivery Devices Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Nasal Delivery Devices Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Respiratory Diseases
5.1.2 Superior Outcomes of Intranasal Drug Delivery Among Patients
5.2 Market Restraints
5.2.1 Limitations Regarding Nasal Drug Delivery Medications
5.3 Market Opportunities
5.3.1 Growing Awareness of Nasal Drug Delivery Amongst Patients
5.4 Future Trends
5.4.1 Increasing Number of Drug Approvals for Nasal Drug Delivery Devices
5.5 Impact Analysis
6. Nasal Delivery Devices Market – North America Analysis
6.1 North America Nasal Delivery Devices Market Revenue Forecasts and Analysis
7. North America Nasal Delivery Devices Market Analysis and Forecasts To 2027 – By Drug Type
7.1 Overview
7.2 Nasal Delivery Devices Market Revenue Share, by Drug Type(2019 and 2027)
7.3 Anaesthetics
7.3.1 Overview
7.3.2 Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.4 Antibiotics
7.4.1 Overview
7.4.2 Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.5 Pain Relief Drugs
7.5.1 Overview
7.5.2 Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.6 Calcium Supplements
7.6.1 Overview
7.6.2 Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.7 Vasoconstrictors
7.7.1 Overview
7.7.2 Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.8 Antihistamines
7.8.1 Overview
7.8.2 Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8. North America Nasal Delivery Devices Market Analysis – By Delivery Technologies
8.1 Overview
8.2 Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)
8.3 Spray
8.3.1 Overview
8.3.2 Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.4 Nebulizers
8.4.1 Overview
8.4.2 Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.5 Inhalers
8.5.1 Overview
8.5.2 Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9. North America Nasal Delivery Devices Market Analysis – By End-User
9.1 Overview
9.2 Nasal Delivery Devices Market Revenue Share, by End -User(2019 and 2027)
9.3 Home Care Settings
9.3.1 Overview
9.3.2 Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9.5 Clinics
9.5.1 Overview
9.5.2 Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
10. Nasal Delivery Devices Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America: Nasal Delivery Devices Market
10.1.1 Overview
10.1.2 North America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
10.1.7 US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Nasal Delivery Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. COMPANY PROFILES
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AstraZeneca
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Pfizer Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of terms
LIST OF TABLES
Table 1. North America Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. US Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 5. US Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 6. US Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Nasal Delivery Devices Market
LIST OF FIGURES
Figure 1. Nasal Delivery DevicesMarket Segmentation
Figure 2. North America Nasal Delivery Devices Market Overview
Figure 3. Antihistamines Segment Held Largest Share of Drug Type in Nasal Delivery DevicesMarket
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Nasal Delivery Devices Market - North America PEST Analysis
Figure 6. Nasal Delivery Devices Market Impact Analysis of Driver and Restraints
Figure 7. North America Nasal Delivery Devices Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)
Figure 9. Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)
Figure 17. Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)
Figure 22. Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 25. North America: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. North America Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 27. North America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
Figure 28. US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in North America Country Markets
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc.
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc.
- To understand the North America nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
- Efficiently plan M&A and partnership deals in North America nasal delivery devices market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region